Indoor environments serve as habitat for humans and are replete with various reservoirs and
niches for microorganisms. Microorganisms enter indoor spaces with their human and non …

Asthma is a major global health issue. Over 300 million people worldwide suffer from this
chronic inflammatory airway disease. Typical clinical symptoms of asthma are characterized …

Background: The persistently high prevalence of allergic diseases in Western industrial
nations and the limited possibilities of causal therapy make evidence-based …

Background Indoor microbiome exposure is associated with asthma, rhinitis and eczema.
However, no studies report the interactions between environmental characteristics, indoor …

In the pathogenesis of asthma in children there is a pivotal role for a type 2 inflammatory
response to early life exposures or events. Interactions between infections, atopy, genetic …

The prevalence of allergic diseases, such as asthma, rhinitis, eczema, and sick building
syndrome (SBS), has increased drastically in the past few decades. Current medications can …

Background: Changes in land use and climate change have been reported to reduce
biodiversity of both the environment and human microbiota. These reductions in biodiversity …

Asia-Pacific is a populous region with remarkable variations in socioeconomic development
and environmental exposure among countries. The prevalence rates of asthma and allergic …

Rural environments and microbiota are linked to a reduction in the prevalence of allergies.
However, the mechanism underlying the reduced allergies modulated by rural residency is …

Approximately 300 million people worldwide are estimated to be affected by asthma, and the
number of patients affected is growing exponentially—with potential for an additional 100 …